Elementis PLC Director Declaration (2349D)
01 Marzo 2022 - 08:03AM
UK Regulatory
TIDMELM
RNS Number : 2349D
Elementis PLC
01 March 2022
1 March 2022
Elementis plc (the "Company") - Director declaration
In accordance with Listing Rule 9.6.14, the Company today
confirms that Anne Hyland, one of its non-executive directors, has
been appointed as a non-executive director of Mereo BioPharma Group
Plc, a biopharmaceutical company developing and commercialising new
therapies for oncology and rare diseases, which is listed on the
NASDAQ exchange under MREO ticker.
Laura Higgins
Group Company Secretary
020 7067 2999
LEI: 549300LQIH685LI2ML36
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RDNSSFFLFEESESD
(END) Dow Jones Newswires
March 01, 2022 09:03 ET (14:03 GMT)
Elementis (LSE:ELM)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Elementis (LSE:ELM)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024